The primary endpoint showed no significant difference between cerebrolysin and placebo groups for the overall population
Their versatility in promoting healing, modulating biological processes, and serving as drug candidates positions them as essential tools in modern medicine, offering hope for more efficient treatments for a variety of conditions, including wounds, infections, and chronic diseases
LIFT-AD Phase 2/3 Failure The larger LIFT-AD trial fails both primary and key secondary endpoints, raising questions about the clinical viability of fosgonimeton
As a research chemical, Dihexa's identity and purity depend entirely on the supplier's COA
Some theoretical concerns (BPC-157 angiogenesis potentially problematic with anti-VEGF though no evidence of issues, peptides affecting blood pressure combined with pressure medications)
(If you want to try it, Live Vital offers Tesamorelin as a prescribed protocol through a licensed pharmacy.) He does not give standalone protocols for these
